The synergetic attenuation of pancreatic redox imbalance, dyslipidemia; modulation of glucose and insulin homeostasis; as well as improved pancreatic β-cell distribution and function suggests possible antidiabetic mechanisms. Here, INS is linked to metabolic syndrome.